These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17643727)

  • 1. Octreotide and post-ERCP pancreatitis.
    Kaya E
    Gastrointest Endosc; 2007 Aug; 66(2):420-1; author reply 421-2. PubMed ID: 17643727
    [No Abstract]   [Full Text] [Related]  

  • 2. High dose of octreotide as a prophylaxis of post-ERCP pancreatitis.
    Andriulli A
    Gastrointest Endosc; 2007 Aug; 66(2):421; author reply 421-2. PubMed ID: 17643730
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
    Andriulli A; Loperfido S
    Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
    [No Abstract]   [Full Text] [Related]  

  • 4. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
    Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in the prevention of post-ERCP pancreatic injury.
    Herszenyi L; Tulassay Z
    Am J Gastroenterol; 2007 Jul; 102(7):1539-40. PubMed ID: 17593164
    [No Abstract]   [Full Text] [Related]  

  • 6. Can octreotide prevent post-ERCP pancreatitis?
    Kaya E
    Am J Gastroenterol; 2007 Jul; 102(7):1540-1; author reply 1541-2. PubMed ID: 17593165
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
    Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
    Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
    Foster E; Leung J
    Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story.
    Testoni PA
    Gastrointest Endosc; 2006 Nov; 64(5):732-4. PubMed ID: 17055866
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.
    Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T
    J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses.
    Zhang Y; Chen QB; Gao ZY; Xie WF
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1155-64. PubMed ID: 19302265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatography.
    Jowell PS; Branch MS; Fein SH; Purich ED; Kilaru R; Robuck G; d'Almada P; Baillie J
    Pancreas; 2011 May; 40(4):533-9. PubMed ID: 21499206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
    Kotrlik J
    Gastrointest Endosc; 1999 Nov; 50(5):728-9. PubMed ID: 10576984
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography.
    Kapetanos D; Christodoulou D; Chatzizisi O; Sigounas D; Vasiliou K; Stavropoulou E; Katodritou E; Kokozidis G; Kiriazis G; Kitis G; Tsianos E
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):529-33. PubMed ID: 19373973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Gostout CJ
    Am J Gastroenterol; 1993 Dec; 88(12):2138-9. PubMed ID: 8249995
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
    Kisli E; Baser M; Aydin M; Guler O
    Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Stas KJ; Lamberts SW
    Am J Gastroenterol; 1993 Sep; 88(9):1461-2. PubMed ID: 8362855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.